Assaf Moore

[Memorial Sloan Kettering Radiation Oncology @MSK_RadOnc]

☢️🧠@NeurosurgeryCNS: This @MSKCancerCenter retrospective review of 102 consecutive pts treated with spine reirradiation. In pts with extensive disease involvement, re #SBRT of spine metastases with 40 Gy in 5 fractions seems to be safe & effective.
https://t.co/oIEnvnSQ3V

[Memorial Sloan Kettering Radiation Oncology @MSK_RadOnc]

Long term results #prostateCancer #SBRT dose escalation: 8-yr PSA failure = 26% (32.5Gy), 15% (35Gy), 3.4% (37.5Gy), & 6.6% (40Gy) with survival free from late G≥2 toxicity 94% (GI tox) & 86% (GU tox) with late tox not associated w/ higher dose. #pcsm
https://t.co/Zen5iCSZZ0